These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1294818)

  • 1. [Treatment experience with rheumatoid arthritis patients during remission].
    Soroka NF
    Klin Med (Mosk); 1992; 70(11-12):37-9. PubMed ID: 1294818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term drug therapy of rheumatoid arthritis and remission].
    Piaĭ L; Piaĭ S
    Ter Arkh; 2000; 72(5):21-5. PubMed ID: 11109613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced remission in the severe progressive variant of rheumatoid arthritis].
    Krel' AA; Semenova OIu; Kanevskaia MZ; Shekhter AB
    Ter Arkh; 1994; 66(1):24-9. PubMed ID: 8146788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The preliminary results of using tramal in rheumatoid arthritis patients].
    Makolkin VI; Bazhanov NN; Petukhova NV; Men'shikova IV
    Ter Arkh; 1992; 64(5):53-4. PubMed ID: 1455376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The possibilities for a modifying influence of basic therapy on the long-term course of rheumatoid arthritis].
    Krel' AA; Semenova OIu; Kanevskaia MZ
    Ter Arkh; 1992; 64(5):41-7. PubMed ID: 1455373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis].
    Ishii O; Yamada H; Ohya S; Moriuchi E; Kase C; Ichikawa Y; Yamasaki K
    Ryumachi; 1997 Dec; 37(6):810-5. PubMed ID: 9492569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The comparative effectiveness of using basic preparations in the combined therapy of rheumatoid arthritis].
    Tsitlanadze VG; Shalamberidze LP; Dzidziguri LM; Kartvelishvili EIu; Shakulashvili NA; Gegeshidze DG; Astvatsaturova TR
    Ter Arkh; 1991; 63(5):101-5. PubMed ID: 1679569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Pasquetti P; Olivieri I; Salvarani C
    Rheumatology (Oxford); 2008 Jun; 47(6):872-6. PubMed ID: 18400836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency and prognostic features of rheumatoid patients with remission-inducing agents--a comparison of different kinds of medication].
    Kutsuna T; Maeda K; Okamoto T; Kawaguchi M
    Ryumachi; 1990 Oct; 30(5):336-42. PubMed ID: 2084855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW
    J Rheumatol; 2006 May; 33(5):854-61. PubMed ID: 16541481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
    Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.